Dynamite: Cast Iron Evidence that Physician, Vaccine Researcher, and Chief Advisor, Operation Warp Speed, Moncef Slaoui, Masterminded the Global Roll Out of SARS-CoV-2 Jabs
This is not just dynamite, it's nuclear!
Beyond all doubt, this is the man behind the SARS-CoV-2 injections evil
Moncef Slaoui, Physician, Vaccine Researcher, and Chief Advisor, Operation Warp Speed, Born in: Morocco
“During a nearly 30-year career at GlaxoSmithKline (GSK), including a position as head of research and development, Slaoui oversaw the development of a number of vaccines, including vaccines to prevent cervical cancer, gastroenteritis, shingles, pneumococcal disease, and Ebola. Slaoui spent 27 years researching a vaccine for malaria. Although largely eradicated in developed countries, malaria still kills more than 400,000 people annually — most of them children in sub-Saharan Africa. In 2015, Mosquirix, the world's first vaccine for the dreaded disease, was approved by the European Medical Agency. “I cried — it’s very personal,” Slaoui recalled on hearing the news of the vaccine’s approval after his decades-long quest. He retired from GSK in 2017. Two years later, the first doses of the malaria vaccine Slaoui and his team at GSK had developed were administered to children in Ghana, Kenya, and Malawi in a World Health Organization–coordinated pilot program.”
What does the above tell you?
Speaks for itself, eh? A lifetime testing experimental jabs on poor, unsuspecting third world countries. Bill Gates isn’t mentioned, but this is his stomping ground, is it not? Chris Whitty was working in the same terrain:
During this time, with co-authors Neil Ferguson and Jeremy Farrar, he wrote an article in Nature titled "Infectious disease: Tough choices to reduce Ebola transmission", explaining the UK government's response to Ebola in support of the government of Sierra Leone, which he took a leading role in designing, including the proposal to build and support centres where people could self-isolate voluntarily if they suspected that they could have the disease.
Jeremy Farrar is there too, the world’s second biggest spender on pharmaceutical research second only to Anthony Fauci; and Ferguson of course, who couldn’t forecast his next meal, let alone a plandemic.
The Plot Thickens
This is where it gets really interesting. When he left GS in 2017, Slauoui went to work for, wait for it, Moderna:
Good News For The World' — Chief Science Adviser Responds To Vaccine Advances
Moderna didn’t have a capability of manufacturing a complex biologic product such as an mRNA experimental jab, so Slauoui signed up Lonza, in Switzerland.
Dr Moncef Slaoui and Lonza
Dr Moncef Slaoui brings to Lonza extensive experience from his career with GlaxoSmithKline spanning nearly 30 years. In this time, he held a number of leadership positions, including Member of the Board of GSK PLC, Chairman of Pharmaceutical R&D; and Chairman of Global Vaccines. Currently, Dr Slaoui is partner at Medicxi, a venture capital firm specializing in seed, Series A, early stage and late stage life sciences investments; he also sits on various biotechnology companies’ boards. Dr Slaoui received his Ph.D. in Molecular Biology and Immunology from Brussels University in 1983. He later received an accelerated Master of Business Administration from IMD in Lausanne (Switzerland) in 1998.
Public Company Board Mandates: Independent Member of the Board of Directors of Moderna (since 2017).
So, 2017 would have been about the time they needed to begin sourcing raw and starting materials, glass vials, rubber bungs and aluminum seals, etc, to get billions of injections manufactured ready for the 2020 ‘outbreak’.
The Plot Goes Global, with Sir Richard Sykes
This recent post then explains how the UK Vaccine Task Force Chair, Sir Richard Sykes, did the EU/UK co-ordination, with Slaoui, Moderna, Lonza, and no doubt, BioNTech and Pfizer, forming a team capable of scamming the world for massive profts:
Is GlaxoSmithKline (GSK) behind global warp speed jabs? The evidence says it is!
INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. More dot joining to lead us to the baddies In this recent post, I said this: Subscriber Alison Wright commented on the post below, pointing out that the Chair of GSK since 2019 has eight different identities for his business dealings!
More on this coming soon, keep your seatbelts fastened!!!